Medtronic Heart Valves Division FDA Inspection Record

FEI 2025587 · Inspections, Form 483s, warning letters and import refusals

Medtronic Heart Valves Division is an FDA-registered facility (FEI 2025587) located in Santa Ana, CA, US. RegDataLab tracks 7 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Oct 26, 2020: No Action Indicated (NAI)
Inspections on record
7 (2 VAI, 5 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
8, latest May 22, 2026
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Oct 26, 2020No Action Indicated (NAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Investigation of device failures (21 CFR 820.198(c))
Mar 30, 2016Voluntary Action Indicated (VAI)Investigation of device failures (21 CFR 820.198(c))
Process control procedures, Lack of or inadequate procedures (21 CFR 820.70(a))
Mar 9, 2015No Action Indicated (NAI)No citations listed
Mar 7, 2014No Action Indicated (NAI)No citations listed
Sep 3, 2013No Action Indicated (NAI)No citations listed
Jun 24, 2010No Action Indicated (NAI)Complaints (21 CFR 820.198(a))
Investigation of device failures (21 CFR 820.198(c))
Training records (21 CFR 820.25(b))
Dec 19, 2008Voluntary Action Indicated (VAI)Lack/Inad procedure-Monitoring/Control of Validated Proces (21 CFR 820.75(b))
Calibration documentation (21 CFR 820.72(b)(2))
Investigation procedures (21 CFR 820.100(a)(2))
Investigation (21 CFR 820.100(a)(2))
and 1 more

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
May 22, 2026Class IZ-2624-2026Medtronic Harmony Delivery Catheter System
Devices containing inner shaft assemblies from specific manufacturing lots may have an increased potential for distal tip detachment from…
Jun 11, 2021Class IIZ-2041-2021CoreValve Evolut R Delivery Catheter System, REF: ENVEOR-L; ENVEOR-N; and 2 more products
Due to reports of actuator separation for various delivery catheter systems. Affected products were manufactured before July 11, 2020.
Oct 23, 2020Class IIZ-0559-2021Evolut (TM) R System. With the following model numbers: a. EVOLUTR-23, Labeled as… and 2 more products
Potential for Transcatheter Aortic Valve (TAV) leaflet damage when performing a post-implant balloon dilatation (PID).
Jan 14, 2020Class IIZ-1449-2020Medtronic Simulus 750 Flexible Ring/Band Accessory Kit - Product Usage: Used to size a… and 1 more product
Demonstration Simulus Reusable Sizer Accessory Kits were being incorrectly sourced to customers. The demonstration product (product used…
Aug 3, 2016Class IIZ-2546-2016Medtronic EnVeo R Delivery Catheter System (DCS), Models: ENVEOR-L, ENVEOR-L-C, and…
Potential for vascular trauma with the use of the Medtronic EnVeo R Delivery Catheter System (DCS).
Jul 15, 2015Class IZ-2264-2015EnVeo R Loading System, Model No. LS-EnVeoR-23, LS-EnVeoR-2629, LS-EnVeoR-23-C…
Medtronic is recalling the EnVeo R Loading Systems because of the presence of particulate.
Aug 15, 2014Class IIZ-2623-2014Hancock Apical Left Ventricle Connector, Model No. H174Axx, Catalog No…
Medtronic has decided to discontinue production and distribution of this low-volume product.
Jan 9, 2014Class IIZ-0908-2014Product Name: Model 7305- Mosaic Aortic Obturator The Mosaic Aortic Obturators are used…
Medtronic, Inc. initiated a recall of Medtronic Mosaic Aortic Obturator Model 7305 used with the Mosaic Porcine Aortic Bioprosthesis…

FDA record score

18 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

10 records behind this number
RecordDatePoints x age weightAdds
Class I recall Z-2624-2026, this FEI as the recalling firmMay 22, 202615 x 115
Class II recall Z-2041-2021, this FEI as the recalling firmJun 11, 20214 x 0.251
Class II recall Z-0559-2021, this FEI as the recalling firmOct 23, 20204 x 0.251
Class II recall Z-1449-2020, this FEI as the recalling firmJan 14, 20204 x 0.251
Class II recall Z-2546-2016, this FEI as the recalling firmAug 3, 201610 years or older, so it adds no points0
Inspection classified VAIMar 30, 201610 years or older, so it adds no points0
Class I recall Z-2264-2015, this FEI as the recalling firmJul 15, 201510 years or older, so it adds no points0
Class II recall Z-2623-2014, this FEI as the recalling firmAug 15, 201410 years or older, so it adds no points0
Class II recall Z-0908-2014, this FEI as the recalling firmJan 9, 201410 years or older, so it adds no points0
Inspection classified VAIDec 19, 200810 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Medtronic Heart Valves Division as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Medtronic Heart Valves Division yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Medtronic Heart Valves Division
Location
Santa Ana, CA (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.